Clinical Trial Update: Does ALlopurinol Regress lefT Ventricular Hypertrophy in End Stage REnal Disease: The ALTERED Study [Phase 4]

View source ↗

Summary

Phase 4 ALTERED study investigating whether allopurinol can regress left ventricular hypertrophy in patients with end-stage renal disease; the trial status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Left Ventricular Hypertrophy

Drugs mentioned

• Allopurinol (Allopurinol)

Snippet

Sponsor: University of Dundee | Conditions: End Stage Renal Disease, Left Ventricular Hypertrophy | Phase 4 | Status: COMPLETED